Key result
Medical therapy, revascularization, and novel technologies show varying efficacy for reducing chronic angina and ischemic events.
Why the study?
Stable angina pectoris is a common presentation of coronary artery disease, and its management requires relieving symptoms, slowing disease progression, preventing future myocardial infarction, and improving survival, including for patients refractory to standard drugs and revascularisation.
This article reviews the available pharmacological, interventional, and novel treatment modalities for managing stable angina pectoris.
Answers are grounded in this paper and cite their sources.
Offers clinicians a consolidated reference for stable angina; leaves open gaps in comparative effectiveness for novel agents.
oronary artery disease is still highly prevalent worldwide, and stable angina pectoris is one of its more common presentations.Stable angina is a clinical expression of myocardial ischaemia associated with fixed atherosclerotic coronary stenosis, which prevents the adaptation of coronary perfusion to an increased oxygen requirement.The goals of treatment include relief of symptoms, inhibition or slowing of disease progression, prevention of future cardiac events such as myocardial infarction (MI), and improved survival.This article reviews the treatment modalities currently available to alleviate the symptoms of chronic angina and to reduce the risk of future MI and cardiac death, including several novel pharmacological treatments, coronary revascularisation, as well as novel technologies that may benefit selected groups of patients who are refractory to both drugs and revascularisation (fig 1). ANTIANGINAL AND ANTI-ISCHAEMIC DRUGSc
No takes yet. Share an insight, caveat, or question.
Ben‐Dor et al. (2007) conducted a review in Stable angina pectoris. Pharmacological treatments, coronary revascularisation, and novel technologies was evaluated on Alleviation of chronic angina symptoms and reduction in the risk of future myocardial infarction and cardiac death. Pharmacological treatments, coronary revascularisation, and novel technologies are reviewed for alleviating chronic angina symptoms and reducing future myocardial infarction and cardiac death.
Synapse has enriched 10 related papers. Consider them for comparative context: